Foot Osteomyelitis (Bone Infection) | Michigan Podiatrist | Balance Foot & Ankle

What Is Foot Osteomyelitis?

Osteomyelitis — infection of bone — is among the most serious and limb-threatening complications in all of foot and ankle medicine. In the context of diabetic foot disease, osteomyelitis develops most commonly through contiguous spread: bacteria colonizing a foot ulcer progressively invade the underlying soft tissue, and when the ulcer overlies or communicates with bone, bacterial invasion of the bone itself occurs. The infected bone provides a protected reservoir for bacteria, shielded from the immune system and many antibiotics by poor vascularity and the biofilm that bacteria form on bone surfaces. Without aggressive treatment — specifically tailored antibiotic therapy guided by bone culture and, in most cases, surgical debridement or resection — osteomyelitis leads to progressive bone destruction, uncontrolled infection, and amputation.

Who Gets Foot Osteomyelitis?

The overwhelming majority of foot osteomyelitis cases occur in patients with diabetic peripheral neuropathy. Loss of protective sensation allows plantar ulcers to develop and progress unnoticed; these chronic wounds become colonized with bacteria that progressively invade deeper structures. The presence of peripheral arterial disease — impaired blood flow to the foot — compounds the risk by reducing immune cell delivery and antibiotic penetration to infected tissue. Immunocompromising conditions (renal failure, immunosuppressive medications, HIV) increase susceptibility. Non-diabetic osteomyelitis occurs through hematogenous spread (blood-borne seeding from a distant infectious source) or as a post-surgical complication — but these pathways are less common than the diabetic ulcer-contiguous route.

Which Bones Are Affected?

The location of osteomyelitis directly reflects the anatomical distribution of diabetic foot ulcers. Plantar forefoot ulcers — the most common diabetic ulcer type — typically overlie metatarsal heads, producing osteomyelitis of the distal metatarsal and proximal phalanx. Heel ulcers produce calcaneal osteomyelitis — the most challenging form, given the calcaneus’s large volume, poor vascularity, and structural importance. Toe tip ulcers cause distal phalanx osteomyelitis, which is the most readily treated by simple distal phalangectomy. In Charcot neuroarthropathy with plantar ulceration, midfoot bone osteomyelitis can involve multiple tarsal bones simultaneously.

Diagnosis: Combining Clinical, Laboratory, and Imaging Assessment

Probe-to-bone test: In a diabetic patient with a foot ulcer, inserting a sterile blunt metal probe into the wound base and feeling bone — a gritty, hard resistance distinct from the soft tissue floor — has 89% sensitivity and 85% specificity for underlying osteomyelitis. A positive probe-to-bone test should be assumed to represent osteomyelitis until proven otherwise. This simple bedside maneuver is among the most useful tests in diabetic wound care.

Inflammatory markers: Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) are elevated in osteomyelitis. An ESR greater than 70 mm/hour in a diabetic patient with a non-healing wound is highly suspicious. White blood cell count may be normal or only mildly elevated — osteomyelitis does not always produce systemic leukocytosis, particularly in immunocompromised patients.

X-ray: Plain radiographs show periosteal reaction, cortical erosion, and bone destruction — but these changes lag bone infection by 10–14 days. Early osteomyelitis may be radiographically occult. Comparison with prior films helps identify subtle interval changes.

MRI: The gold standard for osteomyelitis diagnosis. T1-weighted images show replacement of normal marrow fat signal by low signal (edema, pus, granulation tissue). T2 and STIR sequences show high signal (edema and fluid). Gadolinium enhancement identifies the extent of bone involvement and adjacent soft tissue involvement. MRI is positive before X-ray changes appear and provides precise anatomic definition for surgical planning.

Bone biopsy: The definitive diagnostic and therapeutic tool. A bone specimen sent for culture and pathology confirms infection and identifies the causative organism(s) with sensitivity to specific antibiotics — enabling targeted, culture-directed therapy rather than empirical broad-spectrum coverage. Bone biopsy during surgical debridement combines diagnosis with treatment.

Treatment: Antibiotics Plus Surgery

Osteomyelitis treatment requires adequate antimicrobial therapy AND removal or debridement of infected bone — because antibiotic penetration into avascular bone is poor and biofilm-forming bacteria survive antibiotic exposure without surgical disruption of the infected focus.

Antibiotic therapy: Six weeks of culture-directed intravenous or highly bioavailable oral antibiotic therapy is the standard treatment duration for osteomyelitis. Antibiotics alone — without surgery — are sometimes used for small-volume, easily penetrated bone infections or when surgery carries prohibitive risk. However, antibiotic-alone treatment has significantly higher failure rates than combined surgical-antibiotic management.

Surgical debridement: Removal of infected, devitalized bone to healthy bleeding margins. The quality of the debridement — ensuring all infected tissue is removed — is the strongest predictor of cure. Inadequate debridement leaves residual infected bone that serves as a nidus for relapse.

Partial ray amputation: In diabetic forefoot osteomyelitis, partial ray resection — removal of the infected metatarsal and its associated toe — is often the most reliable treatment. Ray amputation removes the entire infected bone with clear margins, provides excellent tissue for culture, and leaves a functional, shoeable foot when the wound heals. The resulting forefoot is narrower but fully functional with appropriate footwear and orthotics.

Below-knee amputation: Reserved for cases where the extent of infection and tissue destruction makes foot salvage impossible — extensive multifocal osteomyelitis, severe peripheral arterial disease compromising healing, or patient factors that make complex wound management untenable. Modern vascular and podiatric surgical expertise has dramatically reduced the threshold cases that reach below-knee amputation.

Preventing Osteomyelitis: The Upstream Intervention

Osteomyelitis is the downstream endpoint of a preventable cascade: diabetic neuropathy → loss of protective sensation → unnoticed trauma → foot ulcer → ulcer colonization → osteomyelitis. Every intervention that prevents ulcers prevents osteomyelitis. Annual foot examination, therapeutic diabetic footwear, regular nail and callus debridement, glycemic optimization, and patient education about daily foot inspection are the proven strategies that break the cascade before it reaches bone.

Dr. Tom's Product Recommendations

Propet Men’s Stability Walker Diabetic Shoe

⭐ Highly Rated | Foundation Wellness Partner | 30% Commission

Extra-depth therapeutic diabetic shoe with seamless interior and accommodative insole capacity — foundational ulcer-prevention footwear that reduces the plantar pressure that drives the ulcer-osteomyelitis cascade.

Dr. Tom says: “”After my osteomyelitis treatment and partial ray amputation, my podiatrist prescribed these diabetic shoes with custom insoles to prevent future ulcers. Three years later, no recurrence.””

✅ Best for
Diabetic ulcer prevention, post-osteomyelitis and partial ray amputation protective footwear

⚠️ Not ideal for
Patients with active osteomyelitis or open wounds — these require medical wound management, not footwear

View on Amazon →

Disclosure: We earn a commission at no extra cost to you.

Thermoskin Compression Diabetic Socks

⭐ Highly Rated | Foundation Wellness Partner | 30% Commission

Graduated compression socks specifically designed for diabetic patients — improve venous return without constricting arterial flow, reducing foot edema that impairs wound healing and antibiotic delivery.

Dr. Tom says: “”My wound care team recommended these compression socks after my foot infection to reduce swelling and improve circulation. My wound healed faster than expected.””

✅ Best for
Diabetic foot edema management, post-osteomyelitis wound healing support, venous insufficiency in diabetics

⚠️ Not ideal for
Patients with severe peripheral arterial disease — compression is contraindicated when arterial flow is critically compromised

View on Amazon →

Disclosure: We earn a commission at no extra cost to you.

Dr. Tom Biernacki, DPM

Dr. Tom Biernacki, DPM is a double board-certified podiatrist and foot & ankle surgeon at Balance Foot & Ankle Specialists in Southeast Michigan. With over a decade of clinical experience, he specializes in heel pain, bunions, diabetic foot care, sports injuries, and minimally invasive surgery. Dr. Biernacki is a member of the APMA and ACFAS, and his patient education content on MichiganFootDoctors.com and YouTube has reached over one million views.